Literature DB >> 24649294

Determination of the most effective cooling temperature for the prevention of chemotherapy-induced alopecia.

Eva M Ekwall1, Lisa M L Nygren2, Anders O Gustafsson3, Bengt G Sorbe1.   

Abstract

Computer-controlled scalp cooling to prevent alopecia is currently available for patients undergoing chemo-therapy. Previous studies have suggested that the temperature should be <22°C at a depth of 1-2 mm in the scalp to prevent alopecia. However, the optimal pre-set temperature of the coolant medium to achieve this temperature requires further investigation. A pre-study was conducted to investigate which pre-set coolant temperature of 3 and 8°C was the most effective in achieving a scalp temperature of <22°C. The temperature variations at different sites of the scalp and variations within and among the participants at baseline and during the cooling procedure were also evaluated. A randomized main study was then performed to compare the efficacy and side effects of the two temperature levels during paclitaxel/carboplatin chemotherapy. A group of 5 healthy female volunteers participated in a series of scalp temperature measurements during cooling with 3 and 8°C of the coolant medium. In the randomized main study, a total of 47 patients were included, of whom 43 were evaluable after the first cycle. A pre-set temperature of 3°C tended to be the most efficient in achieving a hair follicle temperature of <22°C. The top of the head was less responsive to scalp cooling. There were no significant differences in the prevention of alopecia between the two temperatures in the main study. However, headache and a feeling of coldness were more common in the 3°C group. A coolant temperature of 3°C was more effective in achieving a subcutaneous temperature of <22°C. However, this finding was not reflected by a significant difference in the prevention of alopecia in this study, although a higher incidence of side effects was associated with a lower temperature level.

Entities:  

Keywords:  alopecia; chemotherapy; scalp cooling; side effects

Year:  2013        PMID: 24649294      PMCID: PMC3915696          DOI: 10.3892/mco.2013.178

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  24 in total

1.  Effectiveness of the MSC cold cap system in the prevention of chemotherapy-induced alopecia.

Authors:  C Christodoulou; G Klouvas; E Efstathiou; D Zervakis; E Papazachariou; M Plyta; D V Skarlos
Journal:  Oncology       Date:  2002       Impact factor: 2.935

Review 2.  What is wrong with the 30-year-old practice of scalp cooling for the prevention of chemotherapy-induced hair loss?

Authors:  Wim P M Breed
Journal:  Support Care Cancer       Date:  2003-11-13       Impact factor: 3.603

3.  Modelling of temperature and perfusion during scalp cooling.

Authors:  F E M Janssen; G M J Van Leeuwen; A A Van Steenhoven
Journal:  Phys Med Biol       Date:  2005-08-17       Impact factor: 3.609

Review 4.  Self-concept and cancer: understanding the nursing role.

Authors:  N F Cook
Journal:  Br J Nurs       Date:  1999 Mar 11-24

Review 5.  Prevention of chemotherapy-induced hair loss by scalp cooling.

Authors:  E G Grevelman; W P M Breed
Journal:  Ann Oncol       Date:  2005-01-10       Impact factor: 32.976

Review 6.  Psychosocial management of patients with recurrent ovarian cancer: treating the whole patient to improve quality of life.

Authors:  Margaret I Fitch
Journal:  Semin Oncol Nurs       Date:  2003-08       Impact factor: 2.315

7.  A multicentre study to determine the efficacy and patient acceptability of the Paxman Scalp Cooler to prevent hair loss in patients receiving chemotherapy.

Authors:  Carolyn S Massey
Journal:  Eur J Oncol Nurs       Date:  2004-06       Impact factor: 2.398

8.  Scalp hypothermia to prevent chemotherapy-induced alopecia is effective and safe: a pilot study of a new digitized scalp-cooling system used in 74 patients.

Authors:  Mona Ridderheim; Maria Bjurberg; Anita Gustavsson
Journal:  Support Care Cancer       Date:  2003-03-21       Impact factor: 3.603

9.  Cancer and stigma: experience of patients with chemotherapy-induced alopecia.

Authors:  Sophia Rosman
Journal:  Patient Educ Couns       Date:  2004-03

Review 10.  Scalp cooling has no place in the prevention of alopecia in adjuvant chemotherapy for breast cancer.

Authors:  R A Tollenaar; G J Liefers; O J Repelaer van Driel; C J van de Velde
Journal:  Eur J Cancer       Date:  1994       Impact factor: 9.162

View more
  1 in total

1.  Association Between Use of a Scalp Cooling Device and Alopecia After Chemotherapy for Breast Cancer.

Authors:  Hope S Rugo; Paula Klein; Susan Anitra Melin; Sara A Hurvitz; Michelle E Melisko; Anne Moore; Glen Park; Jules Mitchel; Erika Bågeman; Ralph B D'Agostino; Elizabeth S Ver Hoeve; Laura Esserman; Tessa Cigler
Journal:  JAMA       Date:  2017-02-14       Impact factor: 56.272

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.